İsmail Yaşar AVCI, Çakır GÜNEY, CAN Polat EYİGÜN, Hanefi Cem GÜL, Yakup Hakan BAŞARAN, Bülent A. BEŞİRBELLİOĞLU, Ömer COŞKUN, Alaaddin PAHSA, Recai OĞUR, Cengiz Han AÇIKEL

Anti-HAV seroprevalence in Turkish military personnel and its relation with demographic properties

Aim: Turkey is a middle endemic area in terms of Hepatitis A Virus (HAV) infection. Previous studies in Turkey showed that most residents had been infected with HAV by the second decade of life. In this study we aimed to detect the anti-HAV seroprevalence rate in Turkish military personnel and its relation with demographic properties. Materials and methods: Randomly selected 1049 military personnel were enrolled in the study. All were male and their average age was 24.97 ± 6.48 (Range: 20-50) years. A questionnaire about their demographic properties was administered to and informed consent forms were obtained from each subject. Statistical analysis was performed with SSPS 10.0 software (SSPS, Inc, Chicago, Ill., USA). Differences were considered significant when P < 0.05 for 2 tails. Results: Anti-HAV-IgG test yielded a positive result in 889 (84.7%) subjects. The result was positive for 89.9% of the subjects older than 31 years old and 83.3% of the subjects younger than 31 years old (P > 0.05). Of these 1049 subjects, 67.2% were married. Of the anti-HAV-IgG positive subjects, 91.6% were married whereas 81.8% of the anti-HAV-IgG negative subjects were married (P < 0.01). Being a villager was observed as a risk factor for HAV infection and HAV endemicity in Marmara and Karadeniz regions was significantly lower than that in the other regions. The educational level of the subjects and also their parents were found to have an effect on anti-HAV seropositivity. As the educational level of the subjects and their parents increased, the anti-HAV IgG seropositivity decreased (P < 0.01). Conclusion: The results of our study reveal that HAV exposure may increase due to risk factors, such as socioeconomic and infrastructural problems, personal hygiene, and sources of water and food. Improvement in these factors will lead to fewer exposures to HAV.

Anahtar Kelimeler:

Key words: Anti-HAV seroprevalence, demographic properties, military personnel, Turkey

Anti-HAV seroprevalence in Turkish military personnel and its relation with demographic properties

Keywords:

Key words: Anti-HAV seroprevalence, demographic properties, military personnel, Turkey,

PDF

___

http://www.saglik.gov.tr/extras/istatistikler/temel2003/tablo50- şekil71.htm. Accessed 15th March, 2008.
Mistik R: Epidemiological analysis of viral hepatitis in Turkey [Türkiye’de viral hepatitlerin epidemiyolojik analizi]. Viral hepatitis [Viral Hepatitler]. Ankara,VHSD,2007: 9-50.
Akbulut A, Kılıc¸ SS, Felek S, Akbulut HH. The prevalence of hepatitis A in the Elazıg region. Turk J Med Sci 1996; 26: 375- 8.
Poyraz O, Sumer H, Oztop Y, Saygi G, Sumer Z. Investigation of hepatitis A, B and C virus markers in the general population of Sivas region.[Sivas yöresinde genel toplumda hepatit A, B ve C virus belirleyicilerinin araştırılması] Turkish J Infect 1995; 9: 175-8.
Almeida D, Tavares-Neto J, Vitvitski L, Almeida A, Mello C, Santana D, Tatsch F, Paraná R. Serological markers of hepatitis A, B and C viruses in rural communities of the semiarid Brazilian Northeast. Braz J Infect Dis 2006; 10: 317-21.
Kurugol Z. Epidemiology of hepatitis A [Hepatit A epidemiyolojisi]. In: Programme and Congress Book of V. National Symposium on Viral Hepatitis; 2000 Nov 9-11, Ankara, Turkey, Viral Hepatitle Savaşım Dernegi 2000; 20-34.
Sahin KM, Yarkin F, Kocabas E, Ilkit M, Yildirim S, Akan E. Investigation of HAV, HBV and HCV markers in children with acute hepatitis and in healthy children [Akut hepatit ön tanılı cocuklar ile sağlıklı cocuklarda HAV, HBV ve HCV markırlarının araştırılması]. Viral Hepatit Dergisi 1998; 2: 104– 108.
Tanaka J. Hepatitis A shifting epidemiology in Latin America, Vaccine 2000; 18(Suppl. 1): 57–60.
Barzaga NG. Hepatitis A shifting epidemiology in South-East Asia and China, Vaccine 2000; 18(Suppl.1): 61–4.
Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000; 18(Suppl. 1): 65– 7.
Cianciara J. Hepatitis A shifting epidemiology in Poland and Eastern Europe. Vaccine 2000; 18(Suppl. 1): 68–70.
Rezig D, Ouneissa R, Mhiri L, Mejri S, Haddad-Boubaker S, Ben Alaya N, Triki H. Seroprevalences of hepatitis A and E infections in Tunisia. Pathol Biol (Paris) 2008; Jan 4 [Epub ahead of print]
Rey JL, Ramadani Q, Soarès JL, Nicand E, Ibrahime D, Preteni E, Buisson Y, Teyssou R. Sero-epidemiological study of the hepatitis epidemic in Mitrovica in the aftermath of the war in Kosovo (1999). Bull Soc Pathol Exot 2002; 95(1): 3-7
Struchiner CJ, de Almeida LM, de Azevedo RS, Massad E. Hepatitis A incidence rate estimates from a pilot seroprevalence survey in Rio de Janeiro Brazil. Int J Epidemiol 1999; 28:776- 81.
Zago-Gomes MP, Stantolin GC, Perazzio S, Aikawa KH, Gonçalves CS, Pereira FE. Prevalence of anti-hepatits A antibodies in children of different socioeconomic conditions in Vila Velha, ES. Rev Soc Bras Med Trop 2005; 38: 285-9.
Almeida LM, Werneck GL, Cairncross S, Coeli CM, Costa MC, Coletty PE. The epidemiology of hepatitis A in Rio de Janeiro: environmental and domestic risk factors. Epidemiol Infect 2001; 127(2): 327-33.
http://www.tuik.gov.tr/BolgeselIstatistik/, Accessed 15th March, 2008.